Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T17:47:55.969Z.
Calculation as of: 2026-10-06T17:47:55.969Z.
Quote observation: 2026-10-06T17:45:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d1468b7a76ea597d68349990a611a16a2ef6f087c77b10e193910d6856baa6d
PE RATIO
N/A
Market Cap
$28.86M
PE Ratio
N/A
TTM Avg
1135.14
3Y Avg
1135.14
5Y Avg
1135.14
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $29.71M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.81M | N/A | 0.40 | 0.40 | 0.40 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.86M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $29.72M | N/A | 876.90 | 876.90 | 876.90 |
| Context Therapeutics Inc. (CNTX)vs › | $29.43M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.06M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.36M | N/A | 414.61 | 414.61 | 195.55 |
| MDxHealth S.A. (MDXH)vs › | $30.51M | N/A | N/A | N/A | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.86M | N/A | 1135.14 | 1135.14 | 1135.14 |
| SCYNEXIS, Inc. (SCYX)vs › | $30.81M | N/A | 1.92 | 1.92 | 1.92 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$1.30
Forward EPS (Est.)
$-0.49
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
